Evommune director David E. Cohen disposes of common shares worth $123,166.76

• Evommune director David E. Cohen sold 6,056 common shares on June 2, 2026 at weighted-average prices of USD 20.21 and USD 21.38.
• Holdings fell to 17,609 common shares following the sales.
• Cohen also received stock options for 15,673 shares at an exercise price of USD 19.82, expiring June 1, 2036.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evommune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001347383-26-000003), on June 03, 2026, and is solely responsible for the information contained therein.